Statements (15)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:chemical_compound
|
gptkbp:activities |
modulates immune response
|
gptkbp:application |
gptkb:healthcare_organization
gptkb:psychologist gptkb:rheumatoid_arthritis |
gptkbp:appointed_by |
injection
|
gptkbp:developed_by |
Alchemab Therapeutics
|
https://www.w3.org/2000/01/rdf-schema#label |
ALX-0720
|
gptkbp:is_tested_for |
Phase 1
|
gptkbp:is_used_for |
autoimmune diseases
|
gptkbp:status |
in clinical trials
|
gptkbp:targets |
immune system
|
gptkbp:type |
gptkb:monoclonal_antibody
|
gptkbp:bfsParent |
gptkb:Ablynx
|
gptkbp:bfsLayer |
4
|